RMD vs BAX — Key Metrics

Metric RMD (RESMED INC) BAX (BAXTER INTERNATIONAL INC)
Price242.6126.16
Market Cap34.12 Billion13.53 Billion
P/E (TTM)22.04-18.42
P/B (Quarterly)5.4381.87
P/S (TTM)5.951.17
Net Profit Margin (TTM)27.8-6.2
Gross Margin (TTM)61.130.1
ROE (TTM)25.1-11.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

RESMED INC
vs
 
BAXTER INTERNATIONAL INC
 
RESMED INC
vs
 
BAXTER INTERNATIONAL INC
Performance Comparison
AI Model Recommendation
RMD · RESMED INC

Outperform

46
UnderperformOutperform
BAX · BAXTER INTERNATIONAL INC

Greatly Outperform

88
UnderperformOutperform
Recommendation Summary

Stock RMD is projected to outperform the market, stock BAX is projected to greatly outperform the market. Upfront Recommendation: BAX.

Financial Metrics
Prices delayed ~15 min
RMD Metrics BAX
$242.61 Price $26.16
— Market Capitalization —
5.95 Price to Sales 1.17
21.21 Price to FCF Ratio 11.93
9.75 Price to Gross Profit 3.87
86.65 Price to R&D 26.08
9.73 Price to Current Assets 1.98

RMD vs BAX at a glance

Resmed INC (RMD) and Baxter International INC (BAX) are both Medical Instruments & Supplies companies in the Healthcare sector. RMD is the larger, at $34.1 billion in market value against $13.5 billion for BAX, about 2.5 times the size.

On trailing-twelve-month figures, RMD trades at 6.0 times trailing sales and BAX at 1.2; net profit margins are 27.8% and -6.2%.

The Upfront Investment model currently rates RMD Outperform and BAX Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.